These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 17786312)
1. Experimental treatment of ovarian cancers by adenovirus vectors combining receptor targeting and selective expression of tumor necrosis factor. Murugesan SR; Akiyama M; Einfeld DA; Wickham TJ; King CR Int J Oncol; 2007 Oct; 31(4):813-22. PubMed ID: 17786312 [TBL] [Abstract][Full Text] [Related]
2. Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene. Xiong Z; Cheng Z; Zhang X; Patel M; Wu JC; Gambhir SS; Chen X J Nucl Med; 2006 Jan; 47(1):130-9. PubMed ID: 16391197 [TBL] [Abstract][Full Text] [Related]
3. Fiber-mutant technique can augment gene transduction efficacy and anti-tumor effects against established murine melanoma by cytokine-gene therapy using adenovirus vectors. Okada Y; Okada N; Nakagawa S; Mizuguchi H; Kanehira M; Nishino N; Takahashi K; Mizuno N; Hayakawa T; Mayumi T Cancer Lett; 2002 Mar; 177(1):57-63. PubMed ID: 11809531 [TBL] [Abstract][Full Text] [Related]
4. Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase. Mizuguchi H; Hayakawa T Cancer Gene Ther; 2002 Mar; 9(3):236-42. PubMed ID: 11896439 [TBL] [Abstract][Full Text] [Related]
5. CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice. Mizuguchi H; Koizumi N; Hosono T; Ishii-Watabe A; Uchida E; Utoguchi N; Watanabe Y; Hayakawa T Gene Ther; 2002 Jun; 9(12):769-76. PubMed ID: 12040458 [TBL] [Abstract][Full Text] [Related]
6. Generation of fiber-modified adenovirus vectors containing heterologous peptides in both the HI loop and C terminus of the fiber knob. Koizumi N; Mizuguchi H; Utoguchi N; Watanabe Y; Hayakawa T J Gene Med; 2003 Apr; 5(4):267-76. PubMed ID: 12692861 [TBL] [Abstract][Full Text] [Related]
7. Fetal muscle gene transfer is not enhanced by an RGD capsid modification to high-capacity adenoviral vectors. Bilbao R; Reay DP; Hughes T; Biermann V; Volpers C; Goldberg L; Bergelson J; Kochanek S; Clemens PR Gene Ther; 2003 Oct; 10(21):1821-9. PubMed ID: 12960972 [TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapy. Wu H; Han T; Lam JT; Leath CA; Dmitriev I; Kashentseva E; Barnes MN; Alvarez RD; Curiel DT Gene Ther; 2004 May; 11(10):874-8. PubMed ID: 14999229 [TBL] [Abstract][Full Text] [Related]
9. The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors. Liu Q; Zaiss AK; Colarusso P; Patel K; Haljan G; Wickham TJ; Muruve DA Hum Gene Ther; 2003 May; 14(7):627-43. PubMed ID: 12804145 [TBL] [Abstract][Full Text] [Related]
10. An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches. Vanderkwaak TJ; Wang M; Gómez-Navarro J; Rancourt C; Dmitriev I; Krasnykh V; Barnes M; Siegal GP; Alvarez R; Curiel DT Gynecol Oncol; 1999 Aug; 74(2):227-34. PubMed ID: 10419736 [TBL] [Abstract][Full Text] [Related]
11. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon. Akbulut H; Zhang L; Tang Y; Deisseroth A Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708 [TBL] [Abstract][Full Text] [Related]
12. Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer. Dehari H; Ito Y; Nakamura T; Kobune M; Sasaki K; Yonekura N; Kohama G; Hamada H Cancer Gene Ther; 2003 Jan; 10(1):75-85. PubMed ID: 12489031 [TBL] [Abstract][Full Text] [Related]
13. Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses. Worgall S; Busch A; Rivara M; Bonnyay D; Leopold PL; Merritt R; Hackett NR; Rovelink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG J Virol; 2004 Mar; 78(5):2572-80. PubMed ID: 14963160 [TBL] [Abstract][Full Text] [Related]
15. Enhanced transduction efficiency of fiber-substituted adenovirus vectors by the incorporation of RGD peptides in two distinct regions of the adenovirus serotype 35 fiber knob. Matsui H; Sakurai F; Katayama K; Kurachi S; Tashiro K; Sugio K; Kawabata K; Mizuguchi H Virus Res; 2011 Jan; 155(1):48-54. PubMed ID: 20801174 [TBL] [Abstract][Full Text] [Related]
16. An adenoviral vector containing an arg-gly-asp (RGD) motif in the fiber knob enhances protein product levels from transgenes refractory to expression. Campbell M; Qu S; Wells S; Sugandha H; Jensen RA Cancer Gene Ther; 2003 Jul; 10(7):559-70. PubMed ID: 12833136 [TBL] [Abstract][Full Text] [Related]
17. Genetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapy. Breidenbach M; Rein DT; Wang M; Nettelbeck DM; Hemminki A; Ulasov I; Rivera AR; Everts M; Alvarez RD; Douglas JT; Curiel DT Hum Gene Ther; 2004 May; 15(5):509-18. PubMed ID: 15144580 [TBL] [Abstract][Full Text] [Related]
18. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells. Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877 [TBL] [Abstract][Full Text] [Related]
19. Selectivity of TAG-72-targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitro. Kelly FJ; Miller CR; Buchsbaum DJ; Gomez-Navarro J; Barnes MN; Alvarez RD; Curiel DT Clin Cancer Res; 2000 Nov; 6(11):4323-33. PubMed ID: 11106250 [TBL] [Abstract][Full Text] [Related]
20. Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma. Barker SD; Dmitriev IP; Nettelbeck DM; Liu B; Rivera AA; Alvarez RD; Curiel DT; Hemminki A Gene Ther; 2003 Jul; 10(14):1198-204. PubMed ID: 12833129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]